Forbes March 2, 2023
Topline
The Food and Drug Administration turned down a bid from Neuralink, the ambitious yet controversial human brain chip startup founded by the nation’s richest man Elon Musk, to begin human trials, Reuters reported Thursday, a major setback for the ambitious yet controversial startup even as Musk claims Neuralink’s implants are safe enough for insertion into his and children’s brains.
Key Facts
Key Background
Neuralink, which seeks to assist neurologically and physically impaired people via its Bluetooth-enabled implants, has attracted criticism for the 1,500 animals, including monkeys, that have allegedly died in its experiments. Founded by Musk in 2016, Neuralink has raised $363 million since its inception, according to Crunchbase. In addition to Musk, other notable investors in the company...
Today's Sponsors
Today's Sponsor